Danaher is a diagnostic & research company located in District Of Columbia, United States, which is part of the Healthcare sector, and is traded under the ticker DHR on the NYSE exchange.
Danaher stock last closed at $206.30, up 1.33% from the previous day, and has decreased 16.81% in one year. It has overperformed other stocks in the Diagnostics & Research industry by 0.13 percentage points. Danaher stock is currently +4.83% from its 52-week low of $196.80, and -26.77% from its 52-week high of $281.70.
As of Feb 14, 2025, there are 722.28M shares of DHR outstanding. The market value of DHR is $149.01B. In the last 24 hours, 4.78M DHR shares were traded.
How to Buy Danaher Stock
Wondering how to invest in Danaher stock? Here's how.
Figure out where to buy Danaher stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you choose where to buy Danaher stock.
Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Deposit money your brokerage account: Choose your payment method and add your details.
Research Danaher stock: The Danaher ticker symbol is DHR. Is Danaher stock a good investment? Should you buy shares of DHR? How do DHR's underlying business fundamentals look? Do top analysts think Danaher is a good buy? Why has DHR's stock price moved recently? (Hint: Our stock market analysis website can help you understand if DHR is a good stock to buy).
Place your DHR purchase: Decide if you will purchase DHR shares at the current market price or use a limit order to purchase DHR stock at a specific price.
Get the latest news on your DHR investment: Create a watchlist to get live updates on your investment in Danaher shares.
Step 1: Figure out where to buy Danaher stock
You need a brokerage account in order to access the NYSE market and buy DHR shares.
A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our research, eToro is the best stock brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to global financial markets: From Technology to Industrials, New York to Hong Kong — you can fill your portfolio with stocks from the world's leading stock exchanges.
Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've selected your brokerage, it's time to fill out some personal details so you can invest in DHR today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Danaher stock
Once you have identified the best place to buy Danaher stock, it's crucial to research their stock prior to buying, so you truly comprehend the risk and upside.
Danaher shares quick numbers
DHR Price
$206.30
1w %
-0.22%
1y %
-16.81%
5y %
24.31%
P/E
39x
P/B
2.9x
P/S
7.45x
PEG
1.56x
Revenue
$20.03B
Earnings
$3.89B
Fore. Rev. Growth
13.62%
Fore. Earn. Growth
27.76%
Market Cap
$149.01B
Next Earnings
N/A
Next Dividend
N/A
DHR Due Diligence Checks
WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on DHR's stock page.
How is DHR stock valued?
Investors use many financial metrics, analyses, models, and charts to gauge DHR's true value.
Using relative valuations metrics:
DHR may be overvalued based on its P/E ratio of 39x, relative to Diagnostics & Research industry P/E ratio of 21.72x
DHR may be undervalued based on its P/B ratio of 2.9x, relative to Diagnostics & Research industry P/B ratio of 3.88x
DHR could be overvalued based on its PEG ratio of 1.56x
There are more short-term assets than short-term liabilities on the DHR balance sheet.
Total DHR debt is lower than 5 years ago, relative to shareholder equity.
DHR earnings of $4.63B is not enough to cover its interest payments.
DHR's operating cash flow of $6.29B allows it to safely service it's debt of $17.52B.
Cons:
DHR profit margin has gone down from 27.9% to 19.4% in the past year.
DHR has a relatively high debt to equity ratio of 0.57.
There are more long-term liabilities than short-term assets on the DHR balance sheet.
Do analysts think it's a good time to buy DHR stock
Out of 16 sell side analysts who give recommendations on DHR, the consensus analyst rating on Danaher is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
Latest DHR Analyst Upgrades/Downgrades
Tycho Peterson, a top 18% analyst from Jefferies maintains DHR with a strong buy rating and lowers their DHR price target from $285.00 to $260.00, on Jan 29, 2025.
Andrew Cooper, a bottom 2% analyst from Raymond James maintains DHR with a buy rating and lowers their DHR price target from $300.00 to $275.00, on Jan 21, 2025.
Sung Ji Nam, a bottom 7% analyst from ScotiaBank initiates coverage on DHR with a hold rating and announces their DHR price target of $265.00, on Dec 23, 2024.
Derik De Bruin, a top 15% analyst from Bank of America upgrades DHR to a strong buy rating and maintains their DHR price target from $290.00 to $290.00, on Dec 13, 2024.
Doug Schenkel, a top 36% analyst from Wolfe Research upgrades DHR to a buy rating and announces their DHR price target of $285.00, on Oct 31, 2024.
You can dive deeper into what analysts are projecting on the Danaher stock forecast page.
DHR Trading Indicators
SMA10
207.54
SMA20
223.07
SMA50
229.53
SMA100
242.08
SMA200
251.49
MACD
-9.06
MACD Signal
-7.07
MACD Histogram
-1.99
RSI
30.95
Stochastic %K
11.76
Stochastic %D
7.91
StochRSI %K
10.23
StochRSI %D
4.75
Is DHR Making Money?
Last year, DHR earnings were $3.89B. During the last 5 year, DHR's earnings have grown by 9.18% per year. This was slower than the Diagnostics & Research industry average of 10.97%.
Last year, DHR revenue was $20.03B. Over the past 5 year, DHR's revenue has increased by 5.18% per year. This was slower than the Diagnostics & Research industry average of 9.85%.
No, Danaher doesn't provide an income stream by paying out dividends.
DHR Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your DHR purchase
You have two primary options:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are usually sufficient.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at a particular dollar amount limit, use a limit order.
Hit the Open Trade button and eToro will place the order.
If you want more help with investing in stocks on eToro, click the helpful video below:
As of Feb 14, 2025, it costs $206.30 to buy one share of Danaher stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.485 shares of DHR.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.